A phase 3 randomized, double-blind placebo –controlled trial to evaluate the efficacy and safety of Remdesivir (GS-5734) Treatment of COVID-19 in an outpatient setting (Gilead)

Objective

Clinical Trial Details >>

Principal Investigator(s)
Chad Thury, DO

Clinical Trial Categories

  • Adult
Sponsor(s)
Gilead Sciences
Contact
Avera Research Institute at 605-504-3154
or ARI@Avera.org

Location

  • Avera Medical Group Family Medicine — Marion Rd
    2100 S Marion Rd
    Suite 200
    Sioux Falls, SD 57106
    Main: 605-322-1020
  • Avera Research Institute — Sioux Falls
    6001 S Sharon Ave
    Sioux Falls, SD 57108
    Main: 605-504-3154